Cambridge Institute for Medical Research and Department of Clinical Biochemistry, Addenbrooke's Hospital, Cambridge, UK.
Expert Rev Mol Med. 2010 Jan 5;12:e1. doi: 10.1017/S146239940900132X.
The incretin hormones glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are released from enteroendocrine cells in the intestinal epithelium in response to nutrient ingestion. The actions of GLP-1 and GIP - not only on local gut physiology but also on glucose homeostasis, appetite control and fat metabolism - have made these hormones an attractive area for drug discovery programmes. The potential range of strategies to target the secretion of these hormones therapeutically has been limited by an incomplete understanding of the mechanisms underlying their release. The use of organ and whole-animal perfusion techniques, cell line models and primary L- and K-cells has led to the identification of a variety of pathways involved in the sensing of carbohydrate, fat and protein in the gut lumen. This review focuses on our current understanding of these signalling mechanisms that might underlie nutrient responsiveness of L- and K-cells.
肠内分泌细胞受到营养物质摄入的刺激会分泌肠促胰岛素激素,包括胰高血糖素样肽 1(GLP-1)和葡萄糖依赖性胰岛素释放肽(GIP)。GLP-1 和 GIP 的作用不仅局限于肠道局部的生理学效应,还可以调节葡萄糖稳态、食欲和脂肪代谢,这些作用使它们成为药物研发的热门领域。由于对这些激素分泌释放机制的理解不够深入,在治疗应用中靶向这些激素分泌的策略范围受到了限制。使用器官和整体动物灌流技术、细胞系模型和原代 L 细胞和 K 细胞,已经确定了多种参与肠道腔中碳水化合物、脂肪和蛋白质感知的途径。这篇综述重点介绍了我们目前对这些信号机制的理解,这些机制可能是 L 细胞和 K 细胞对营养物质响应的基础。